Outlook of the global enteric disease testing market
Technavio’s market research analyst predicts the global enteric disease testing market to grow steadily at a CAGR of around 9% during the forecast period. Recently, it has been observed that enteric diseases, such as diarrhea, cholera, and typhoid fever, are on the rise among the global population. Consequently, vendors and academics have developed an isothermal nucleic acid amplification-based diagnostic method, which incorporates all the temperature dependent steps of PCR by utilizing enzymes. Since this technology is highly specific and sensitive, healthcare facilities from across the globe can use this method to rapidly diagnose and detect pathogens. The ability of this technology to efficiently identify pathogens without the use of a thermocycler will result in this market’s impressive growth during the forecast period.
In terms of geography, the Americas accounted for about 50% of the total market share in 2015 and is envisaged to grow steadily at a CAGR of around 6% during the forecast period. Factors such as the high demand for molecular diagnostic tests and the high level of enteric disease awareness among the population will spur market growth in this region until 2020.
Disease-based segmentation of the enteric disease testing market
- Bacterial enteric diseases
- Viral enteric diseases
The bacterial enteric disease segment currently dominates this market and accounts for a market share of approximately 80% during the forecast period. The high prevalence of GI diseases, such as diarrhea and typhoid fever, will fuel the demand for bacterial enteric disease testing among patients during the forecast period.
Segmentation by type of clinical diagnosis and analysis of the enteric disease testing market
Outlook of the blood culture tests market
Extensive research carried out by the analysts at Technavio has shown that the global blood culture tests market will witness tremendous growth and will post a CAGR of more than 7% over the forecast period. With the increasing outsourcing of blood samples to private reference laboratories, the blood culture tests market is anticipated to have a positive outlook in the coming years. Reference laboratories provide testing services for hospitals and in the areas of clinical trials, corporate wellness programs, genomics, insurance, toxicology, molecular diagnostics, and sample tracking. In this market, an increasing number of public hospitals are outsourcing services to independent reference laboratories due to budget constraints, lower turnaround time, and productivity gains, which will, in turn, propel this market’s growth over the next four years.
The augmented demand for rapid diagnostics tests is one of the significant trends impelling this market’s growth during the predicted period. Rapid diagnostics tests offer speedy identification of pathogens; thereby, aiding in the effective targeting of antimicrobial therapy in hospitals. Moreover, these diagnostic tests are cost-effective and accurate. Several advanced technologies like peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) and targeted real-time PCR help lower hospital costs and reduce hospital stays significantly. These benefits emphasize the positive impact of rapid molecular testing in clinical laboratories.
Segmentation by technology and analysis of the blood culture tests market
- Conventional or manual blood culture
- Automated blood culture
During 2015, the conventional or manual blood culture segment dominated the market and accounted for a market share of
Blood processing devices and consumables help in preventing infections in blood transfusion and blood donation procedures. The majority of blood processing devices are extensively used for cell processing, centrifugation of blood cells, and refrigeration of blood. They also find extensive applications in blood collection and grouping by various reagents. Some of the major areas of concerns in the healthcare sector are the increasing incidences of infections and related diseases due to blood transfusion and blood donation. According to the recent statistics, nearly 70 million units of donated blood are used annually in developed countries. Abbott Laboratories and Bio-Rad are some of the leading players identified in this market.
The report, global blood processing devices and consumables market, is part of Technavio’s healthcare and life sciences research portfolio. This portfolio provides a comprehensive market analysis along with the market share, market sizing, and market segmentations covering areas such as cardiovascular and metabolic disorders, central nervous system, oncology, medical imaging, life science research tools, and vaccines. These market research reports provide a perspective on the various market opportunities and market threats along with the key trends that would influence the market growth during the forecast period. It presents insights into the changing competitive landscape and a detailed profiling
Overview of the global cancer diagnostic devices market
Technavio’s market research analyst predicts that the global cancer diagnostic devices market will grow at a significant CAGR of over 18% during the forecast period. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical companies are shifting their focus from drug development to cancer diagnostic devices so that they can help in diagnosing, monitoring, and administering drugs through the cancer treatment process. These devices play a key role in helping pharmaceutical companies develop specific drugs to treat cancer. One such example is Roche’s cobas EGFR mutation test, which diagnoses head and neck cancers. Increased investment in diagnostic device development will boost market growth by the end of 2020.
In this industry report, the analysts estimate factors like the increased R&D spending by vendors to estimate this market’s growth potential over the forecast period. The development of nanoparticle-based theranostics is one such approach. It involves combining therapeutic and diagnostic agents and using gold nanoparticles to monitor targeted tumors in the body. This approach not only helps doctors understand the effect of drugs used to treat cancerous tumors but helps doctors to monitor their progress. The availability of such diagnostic devices will have a positive impact on market growth during the forecast period.
Product-based segmentation and analysis of the cancer diagnostic devices market
- Companion diagnostics
- Molecular diagnostics
The molecular diagnostics segment accounts for the largest share of the cancer diagnostic devices market by revenue and is expected to generate over USD 3 billion by the end of 2020. The market has significant growth
Overview of the global gonorrhea diagnostics market
Technavio’s market research analyst predicts the global gonorrhea diagnostics market to grow at a CAGR of more than 9% by 2020. There has been a recent rise in the incidences of gonorrhea across the globe due to the adoption of risky sexual behavior and unsafe sexual practices. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. The highest occurrence rates of gonorrhea are primarily in heterosexually infected men, especially those aged 25-34 years. These increasing incidences of gonorrhea will enhance the demand for gonorrhea diagnostic products during the forecast period.
The growing use of molecular diagnostics for performing gonorrhea tests is a key trend in this market. Some of the new technologies in molecular diagnostics include PCR-based techniques, nucleic acid amplification tests, and DNA nanotechnology. As a result of the high efficiency, variety, accuracy, and reliability of these gonorrhea tests, the growing use of molecular diagnostics is expected to have a positive impact on the growth of the global gonorrhea diagnostics market during the forecast period.
Segmentation by application and analysis of gonorrhea diagnostics market
- Diagnostic imaging
- Differential light scattering
- Flow cytometry
- Gel microdroplets
- Molecular diagnostics
- Monoclonal antibodies test
The molecular diagnostics procedure involves the nucleic acid extraction mixtures from gonorrhea cultures that act as a template for the diagnosis. The advancement in molecular biology has played a crucial role in the molecular
Market outlook of the global dental implants market
Technavio’s market research analyst predicts that the global dental implants market will grow steadily at a CAGR of approximately 5% by 2020. Recent technological advances in the field of implant dentistry, such as bone augmentation, 3D imaging, and mini dental implants, will propel the adoption of dental implants during the forecast period.
In this market study, analysts estimate eminent factors, such as the augmented adoption of evidence-based dentistry, to drive market growth during the predicted period. Evidence-based dentistry provides an approach to oral healthcare that follows a defined process of systematically collecting and analyzing evidence. The ability of evidence-based dentistry to aid in developing a protocol that makes dental implants more affordable will propel market growth during the forecast period.
Product-based segmentation of the dental implants market
- Titanium implants
- Zirconium implants
In this market research, Technavio analysts have estimated the titanium implants segment to be the largest market segment during the predicted period. Factors like the increasing number of oral diseases coupled with the rising awareness of oral health will lead to this segment’s profound market share of nearly 95% during the forecast period.
Geographical segmentation of the dental implants market
The EMEA region currently accounted for more than 48% of the total market share and is estimated to grow at a CAGR of nearly 5% during the forecast period. Factors such as recent advances in technology, the rise in aging population, and increasing
In-vitro diagnostics is one of the fastest-growing sectors in healthcare. Cost-containment strategies by healthcare entities have led to an increased focus on early diagnosis, preventive medicine, and personalized medicine.
This move towards preventive and personalized medicine is driving the adoption of in-vitro diagnostics, and vendors are focusing on developing tests for a wide range of applications for hospitals and laboratories, as well as for home care. The presence of a high number of market participants has significantly intensified competition.